These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 28819447)
1. Targeting Activated Platelets: A Unique and Potentially Universal Approach for Cancer Imaging. Yap ML; McFadyen JD; Wang X; Zia NA; Hohmann JD; Ziegler M; Yao Y; Pham A; Harris M; Donnelly PS; Hogarth PM; Pietersz GA; Lim B; Peter K Theranostics; 2017; 7(10):2565-2574. PubMed ID: 28819447 [No Abstract] [Full Text] [Related]
2. Activated platelets in the tumor microenvironment for targeting of antibody-drug conjugates to tumors and metastases. Yap ML; McFadyen JD; Wang X; Ziegler M; Chen YC; Willcox A; Nowell CJ; Scott AM; Sloan EK; Hogarth PM; Pietersz GA; Peter K Theranostics; 2019; 9(4):1154-1169. PubMed ID: 30867822 [No Abstract] [Full Text] [Related]
3. Detection of high-risk atherosclerotic plaques with ultrasound molecular imaging of glycoprotein IIb/IIIa receptor on activated platelets. Guo S; Shen S; Wang J; Wang H; Li M; Liu Y; Hou F; Liao Y; Bin J Theranostics; 2015; 5(4):418-30. PubMed ID: 25699100 [TBL] [Abstract][Full Text] [Related]
4. Novel single-chain antibody-targeted microbubbles for molecular ultrasound imaging of thrombosis: validation of a unique noninvasive method for rapid and sensitive detection of thrombi and monitoring of success or failure of thrombolysis in mice. Wang X; Hagemeyer CE; Hohmann JD; Leitner E; Armstrong PC; Jia F; Olschewski M; Needles A; Peter K; Ahrens I Circulation; 2012 Jun; 125(25):3117-26. PubMed ID: 22647975 [TBL] [Abstract][Full Text] [Related]
5. In vivo ultrasound molecular imaging of inflammatory thrombosis in arteries with cyclic Arg-Gly-Asp-modified microbubbles targeted to glycoprotein IIb/IIIa. Wu W; Wang Y; Shen S; Wu J; Guo S; Su L; Hou F; Wang Z; Liao Y; Bin J Invest Radiol; 2013 Nov; 48(11):803-12. PubMed ID: 23857134 [TBL] [Abstract][Full Text] [Related]
6. Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets. Schwarz M; Meade G; Stoll P; Ylanne J; Bassler N; Chen YC; Hagemeyer CE; Ahrens I; Moran N; Kenny D; Fitzgerald D; Bode C; Peter K Circ Res; 2006 Jul; 99(1):25-33. PubMed ID: 16778135 [TBL] [Abstract][Full Text] [Related]
7. Activation of tumour cell ECM degradation by thrombin-activated platelet membranes: potentially a P-selectin and GPIIb/IIIa-dependent process. Pang JH; Coupland LA; Freeman C; Chong BH; Parish CR Clin Exp Metastasis; 2015 Jun; 32(5):495-505. PubMed ID: 25982688 [TBL] [Abstract][Full Text] [Related]
8. Highly Sensitive Detection of Minimal Cardiac Ischemia using Positron Emission Tomography Imaging of Activated Platelets. Ziegler M; Alt K; Paterson BM; Kanellakis P; Bobik A; Donnelly PS; Hagemeyer CE; Peter K Sci Rep; 2016 Dec; 6():38161. PubMed ID: 27909290 [TBL] [Abstract][Full Text] [Related]
9. Delayed targeting of CD39 to activated platelet GPIIb/IIIa via a single-chain antibody: breaking the link between antithrombotic potency and bleeding? Hohmann JD; Wang X; Krajewski S; Selan C; Haller CA; Straub A; Chaikof EL; Nandurkar HH; Hagemeyer CE; Peter K Blood; 2013 Apr; 121(16):3067-75. PubMed ID: 23380744 [TBL] [Abstract][Full Text] [Related]
10. Enzymatic single-chain antibody tagging: a universal approach to targeted molecular imaging and cell homing in cardiovascular disease. Ta HT; Prabhu S; Leitner E; Jia F; von Elverfeldt D; Jackson KE; Heidt T; Nair AK; Pearce H; von Zur Muhlen C; Wang X; Peter K; Hagemeyer CE Circ Res; 2011 Aug; 109(4):365-73. PubMed ID: 21700932 [TBL] [Abstract][Full Text] [Related]
11. In vitro measurement of platelet glycoprotein IIb/IIIa receptor blockade by abciximab: interindividual variation and increased platelet secretion. Rossi F; Rossi E; Pareti FI; Colli S; Tremoli E; Gallo L Haematologica; 2001 Feb; 86(2):192-8. PubMed ID: 11224490 [TBL] [Abstract][Full Text] [Related]
12. Dual targeting improves capture of ultrasound microbubbles towards activated platelets but yields no additional benefit for imaging of arterial thrombosis. Günther F; Heidt T; Kramer M; Khanicheh E; Klibanov AL; Geibel-Zehender A; Ferrante EA; Hilgendorf I; Wolf D; Zirlik A; Reinöhl J; Bode C; Peter K; Kaufmann BA; Mühlen CVZ Sci Rep; 2017 Nov; 7(1):14898. PubMed ID: 29097799 [TBL] [Abstract][Full Text] [Related]
13. Dual-contrast molecular imaging allows noninvasive characterization of myocardial ischemia/reperfusion injury after coronary vessel occlusion in mice by magnetic resonance imaging. von Elverfeldt D; Maier A; Duerschmied D; Braig M; Witsch T; Wang X; Mauler M; Neudorfer I; Menza M; Idzko M; Zirlik A; Heidt T; Bronsert P; Bode C; Peter K; von Zur Muhlen C Circulation; 2014 Aug; 130(8):676-87. PubMed ID: 24951772 [TBL] [Abstract][Full Text] [Related]
14. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa]. Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599 [TBL] [Abstract][Full Text] [Related]
16. Differential inhibition of fibrinogen binding to agonist- and RGDS peptide-activated states of GPIIb-IIIa by an anti-GPIIIa monoclonal antibody, PMA5. Nakatanl S; Hato T; Minamoto Y; Fujita S Thromb Haemost; 1996 Dec; 76(6):1030-7. PubMed ID: 8972028 [TBL] [Abstract][Full Text] [Related]
17. Visualization of activated platelets by targeted magnetic resonance imaging utilizing conformation-specific antibodies against glycoprotein IIb/IIIa. von zur Muhlen C; Peter K; Ali ZA; Schneider JE; McAteer MA; Neubauer S; Channon KM; Bode C; Choudhury RP J Vasc Res; 2009; 46(1):6-14. PubMed ID: 18515970 [TBL] [Abstract][Full Text] [Related]
18. Platelet-Targeted Delivery of Peripheral Blood Mononuclear Cells to the Ischemic Heart Restores Cardiac Function after Ischemia-Reperfusion Injury. Ziegler M; Wang X; Lim B; Leitner E; Klingberg F; Ching V; Yao Y; Huang D; Gao XM; Kiriazis H; Du XJ; Haigh JJ; Bobik A; Hagemeyer CE; Ahrens I; Peter K Theranostics; 2017; 7(13):3192-3206. PubMed ID: 28900504 [TBL] [Abstract][Full Text] [Related]
19. Identification of low molecular weight GP IIb/IIIa antagonists that bind preferentially to activated platelets. Bednar RA; Gaul SL; Hamill TG; Egbertson MS; Shafer JA; Hartman GD; Gould RJ; Bednar B J Pharmacol Exp Ther; 1998 Jun; 285(3):1317-26. PubMed ID: 9618439 [TBL] [Abstract][Full Text] [Related]
20. Single-chain antibody conjugated to a cage amine chelator and labeled with positron-emitting copper-64 for diagnostic imaging of activated platelets. Alt K; Paterson BM; Ardipradja K; Schieber C; Buncic G; Lim B; Poniger SS; Jakoby B; Wang X; O'Keefe GJ; Tochon-Danguy HJ; Scott AM; Ackermann U; Peter K; Donnelly PS; Hagemeyer CE Mol Pharm; 2014 Aug; 11(8):2855-63. PubMed ID: 24999533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]